FHIR © HL7.org  |  Server Home  |  XIG Home  |  Server Source  |  FHIR  

FHIR IG Statistics: ValueSet/valueset-rimexolone-exclude

Packagehl7.fhir.uv.pddi
TypeValueSet
Idvalueset-rimexolone-exclude
FHIR VersionR4
Sourcehttp://hl7.org/fhir/uv/pddi/https://build.fhir.org/ig/HL7/PDDI-CDS/ValueSet-valueset-rimexolone-exclude.html
URLhttp://hl7.org/fhir/uv/pddi/ValueSet/valueset-rimexolone-exclude
Version1.0.0-ballot
Statusdraft
Date2018-07-02
NameValueset_rimexolone_exclude
TitleExclude Rimexolone Medications Value Set
Realmuv
Authorityhl7
DescriptionValueSet containing drug identifiers to exclude. Criteria is explicitly stating topical, gel, cream, ointment, otic, or ophthalmic formulations.
PurposeTo refine valueset for Warfarin + NSAID PDDI-CDS
Copyright(copyright expectations unknown)

Resources that use this resource

No resources found


Resources that this resource uses

CodeSystem
rxnormRxNorm
rxnormRxNorm

Narrative

Note: links and images are rebased to the (stated) source

Generated Narrative: ValueSet valueset-rimexolone-exclude

  • Include these codes as defined in http://www.nlm.nih.gov/research/umls/rxnorm
    CodeDisplay
    207446rimexolone 10 MG/ML Ophthalmic Suspension [Vexol]
    365826rimexolone Ophthalmic Suspension [Vexol]
    199115rimexolone 10 MG/ML Ophthalmic Suspension
    379299rimexolone Ophthalmic Suspension
    1157440rimexolone Ophthalmic Product
    1188083Vexol Ophthalmic Product

Source

{
  "resourceType": "ValueSet",
  "id": "valueset-rimexolone-exclude",
  "text": {
    "status": "generated",
    "div": "<!-- snip (see above) -->"
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
      "valueCode": "cds"
    }
  ],
  "url": "http://hl7.org/fhir/uv/pddi/ValueSet/valueset-rimexolone-exclude",
  "version": "1.0.0-ballot",
  "name": "Valueset_rimexolone_exclude",
  "title": "Exclude Rimexolone Medications Value Set",
  "status": "draft",
  "experimental": true,
  "date": "2018-07-02",
  "publisher": "HL7 Clinical Decision Support Workgroup",
  "contact": [
    {
      "telecom": [
        {
          "system": "url",
          "value": "http://hl7.org/Special/committees/dss"
        }
      ]
    }
  ],
  "description": "ValueSet containing drug identifiers to exclude. Criteria is explicitly stating topical, gel, cream, ointment, otic, or ophthalmic formulations.",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "http://unstats.un.org/unsd/methods/m49/m49.htm",
          "code": "001"
        }
      ]
    }
  ],
  "purpose": "To refine valueset for Warfarin + NSAID PDDI-CDS",
  "copyright": "(copyright expectations unknown)",
  "compose": {
    "include": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "concept": [
          {
            "code": "207446",
            "display": "rimexolone 10 MG/ML Ophthalmic Suspension [Vexol]"
          },
          {
            "code": "365826",
            "display": "rimexolone Ophthalmic Suspension [Vexol]"
          },
          {
            "code": "199115",
            "display": "rimexolone 10 MG/ML Ophthalmic Suspension"
          },
          {
            "code": "379299",
            "display": "rimexolone Ophthalmic Suspension"
          },
          {
            "code": "1157440",
            "display": "rimexolone Ophthalmic Product"
          },
          {
            "code": "1188083",
            "display": "Vexol Ophthalmic Product"
          }
        ]
      }
    ]
  }
}